EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Lipid-lowering Therapy and Coronary Plaque Regression

Yasushi Ueki, Tadashi Itagaki, Koichiro Kuwahara

Journal of Atherosclerosis and Thrombosis · 2024

DOI: 10.5551/jat.rv22024 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Yasushi Ueki und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, Shinshu University Hospital. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Coronary Artery Disease. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid-lowering therapy plays a central role in reducing cardiovascular events. Over the past few decades, clinical trials utilizing several imaging techniques have consistently shown that lipid-lowering therapy can reduce the coronary plaque burden and improve plaque composition. Although intravascular ultrasound has been the most extensively used modality to assess plaque burden, other invasive modalities, such as optical coherence tomography and near-infrared spectroscopy, provide relevant data on plaque vulnerability, and computed tomography angiography detects both plaque volume and characteristics non-invasively. A large body of evidence supports the notion that reducing low-density lipoprotein cholesterol using statins combined with ezetimibe and proprotein convertase subtillisin/kexin type 9 inhibitors consistently shows improvements in plaque burden and favorable morphological changes. This review summarizes previously obtained data on the impact of lipid-lowering treatment strategies on atherosclerotic plaque regression, as assessed using several imaging modalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plaque, AtheroscleroticCoronary Artery DiseaseHumansHydroxymethylglutaryl-CoA Reductase InhibitorsTomography, Optical CoherenceHypolipidemic AgentsAnticholesteremic AgentsCholesterol, LDLUltrasonography, InterventionalEzetimibe

Stichwörter der Autor:innen

Computed tomographyIntravascular ultrasoundLipid-lowering therapyNear-infrared spectroscopyOptical coherence tomographyPlaque regression

Substanzen

Hydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic AgentsAnticholesteremic AgentsCholesterol, LDLEzetimibe

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, Shinshu University Hospital.

Zitieren

APA

Ueki, Y., Itagaki, T., & Kuwahara, K. (2024). Lipid-lowering Therapy and Coronary Plaque Regression. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.rv22024

Vancouver

Ueki Y, Itagaki T, Kuwahara K. Lipid-lowering Therapy and Coronary Plaque Regression. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.rv22024

BibTeX
@article{Ueki2024,
  author = {Ueki, Yasushi and Itagaki, Tadashi and Kuwahara, Koichiro},
  title = {Lipid-lowering Therapy and Coronary Plaque Regression},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  doi = {10.5551/jat.rv22024}
}
Kostenlos starten →